Dapagliflozin in heart failure: new frontiers

被引：5
|
作者：
Tromp, Jasper [1 ,2 ,3 ]
Collins, Sean P. [4 ]
机构：
[1] Natl Heart Ctr Singapore, Dept Cardiol, Singapore, Singapore
[2] Duke NUS Med Sch, Dept Cardiol, Singapore, Singapore
[3] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands
[4] Vanderbilt Univ, Med Ctr, Dept Emergency Med, Nashville, TN USA
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2019年 / 21卷 / 11期
关键词：
D O I：
10.1002/ejhf.1633
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
This article refers to 'The Dapagliflozin And Prevention of Adverse-outcomes in Heart Failure (DAPA-HF) trial: baseline characteristics', by J.J.V. McMurray et al., published in this issue on pages 1402-1411.
引用
收藏
页码：1412 / 1414
页数：3
相关论文
共 50 条
  • [31] Prognosis of patients eligible for dapagliflozin in acute heart failure
    Carballo, Sebastian
    Stirnemann, Jerome
    Garin, Nicolas
    Darbellay Farhoumand, Pauline
    Serratrice, Jacques
    Carballo, David
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2020, 50 (06)
  • [32] Dapagliflozin attenuates diastolic dysfunction in a model of heart failure
    De Angelis, Antonella
    Cappetta, Donato
    Cozzolino, Anna
    D'Amario, Domenico
    Coppini, Raffaele
    Rossi, Francesco
    Berrino, Liberato
    Urbanek, Konrad
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2020, 22 (0N) : N89 - N89
  • [33] The efficacy of dapagliflozin in a hierarchical kidney outcome in heart failure
    Kondo, Toru
    McMurray, John J. V.
    NATURE MEDICINE, 2024, 30 (05) : 1253 - 1254
  • [34] Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
    Borghi, Claudio
    Cicero, Arrigo F. G.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (10): : 972 - 972
  • [35] Dapagliflozin in Patients With Heart Failure and Deterioration in Renal Function
    Chatur, Saha
    Vaduganathan, Muthiah
    Claggett, Brian L.
    Mc Causland, Finnian R.
    Desai, Akshay S.
    Jhund, Pardeep S.
    de Boer, Rudolf A.
    Hernandez, Adrian F.
    Inzucchi, Silvio E.
    Kosiborod, Mikhail N.
    Lam, Carolyn S. P.
    Martinez, Felipe A.
    Shah, Sanjiv J.
    Sabatine, Marc S.
    Kober, Lars
    Ponikowski, Piotr
    Merkely, Bela
    Petersson, Magnus
    Langkilde, Anna Maria
    McMurray, John J. V.
    Solomon, Scott D.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 82 (19) : 1854 - 1863
  • [36] Early Clinical Experience with Dapagliflozin in Children with Heart Failure
    David M. Newland
    Yuk M. Law
    Erin L. Albers
    Joshua M. Friedland-Little
    Humera Ahmed
    Mariska S. Kemna
    Borah J. Hong
    Pediatric Cardiology, 2023, 44 : 146 - 152
  • [37] Dapagliflozin for patients with heart failure and reduced ejection fraction
    Ferry, Abigail
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2022, 35 (09): : 51 - 53
  • [38] Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
    McMurray, J. J. V.
    Solomon, S. D.
    Inzucchi, S. E.
    Kober, L.
    Kosiborod, M. N.
    Martinez, F. A.
    Ponikowski, P.
    Sabatine, M. S.
    Anand, I. S.
    Belohlavek, J.
    Bohm, M.
    Chiang, C. -E.
    Chopra, V. K.
    de Boer, R. A.
    Desai, A. S.
    Diez, M.
    Drozdz, J.
    Dukat, A.
    Ge, J.
    Howlett, J. G.
    Katova, T.
    Kitakaze, M.
    Ljungman, C. E. A.
    Merkely, B.
    Nicolau, J. C.
    O'Meara, E.
    Petrie, M. C.
    Vinh, P. N.
    Schou, M.
    Tereshchenko, S.
    Verma, S.
    Held, C.
    DeMets, D. L.
    Docherty, K. F.
    Jhund, P. S.
    Bengtsson, O.
    Sjostrand, M.
    Langkilde, A. -M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (21): : 1995 - 2008
  • [39] Is Dapagliflozin Cost-effective for Treating Heart Failure?
    Slomski, Anita
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (05): : 378 - 378
  • [40] Nature and Magnitude of the Benefits of Dapagliflozin and Empagliflozin for Heart Failure
    Cleland, John G. F.
    CIRCULATION, 2024, 149 (11) : 839 - 842
12345